 |
|
|
| |
HBV Genotype Is Associated With Early (Week 12) Virologic Response During Tenofovir Disoproxil Fumarate or Tenofovir Alafenamide Therapy in Patients With Chronic Hepatitis B
|
| |
| |
Reported by Jules Levin
AASLD 2016 Nov 11-15 Boston, MA
Subrat K. Acharya, 1 Kwan Sik Lee, 2 Jia-Horng Kao, 3 Robert Flisiak, 4 John F. Flaherty, 5 Kyungpil Kim, 5 Lanjia Lin, 5 Anuj Gaggar, 5 Robert P. Myers, 5 Marina Osipenko, 6 Stephen Pianko, 7 Wan-Cheng Chow, 8 Calvin Q. Pan 9
1All India Institute of Medical Sciences, New Delhi, India; 2Gangnam Severance Hospital, Seoul, Korea; 3Graduate Institute of Clinical Medicine, National Taiwan University Hospital, Taipei, Taiwan; 4Wojewodzki Szpital Specjalistyczny im Dluskeigo, Bialystok, Poland;
5Gilead Sciences, Inc., Foster City, CA; 6Novosibirsk State Medical University, Novosibirsk, Russia; 7Monash Medical Centre, Clayton, Victoria, Australia; 8Singapore General Hospital, Singapore; 9NYU Langone Medical Center, New York, NY
References
1. Babusis D, et al. Mol Pharm 2013;10:459-66; 2. Lee WA, et al. Antimicrob Agents Chemother 2005;49:1898-906; 3. Murakami E, et al. Antimicrob Agents Chemother 2015;59:3563-9; 4. Agarwal K, et al. J Hepatol 2015;62:533-40;
5. Sax P, et al. Lancet 2015;385:2606-15; 6. European Association for the Study of the Liver. J Hepatol 2012;57:167-85; 7. Terrault NA, et al. Hepatology 2016;63:261-83.
|
| |
|
|
|
|
|
